I am delighted to welcome Jan Groen to the Board of Angle. His knowledge and experience of this market will be of significant value to us as we progress the commercialisation of our Parsortix TM liquid biopsy solution. First Flight provided a long list of seven candidates that surprised us with its high quality and relevance, and we would have been pleased to appoint anyone from this list.
Andrew Newland, CEO, Angle plc
